Timed and targeted therapy for acute kidney injury: a glimpse of the future.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 20467432.
- Also identified by DOI 10.1038/ki.2010.79.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Whether and when to intervene and with which therapeutic agent are key questions physicians face daily in managing patients. Biomarkers are emerging to define the course of acute kidney injury and offer an opportunity to provide targeted interventions. The EARLYARF study by Endre et al. provides a glimpse of the challenges and opportunities that lie ahead.
Medical subject headings
- Erythropoietin
- Hematinics
- Kidney Diseases